29, P = 0.0009).[22] No association with lupus nephritis was found with this genotype; www.selleckchem.com/products/byl719.html however, the risk allele was enriched in SLE patients with serositis and low levels of complement.[22] They added these new data to published information from 11 additional studies (spanning China, Taiwan, Japan, Korea, Thailand and Asian populations and varying in size from the 732 patients in this study to as small as 13 in the first published work in this area) to perform a meta-analysis with 2,561 Asian SLE patients (1339 with nephritis, 1131 without nephritis) for association with FcgRIIIa-158F. Association was again found with

the F-allele of FcgRIIIa and SLE (OR [95% CI] = 1.25 [1.12–1.40]), but no longer with lupus nephritis as had been suggested previously with smaller Asian studies.[22] Additional work is warranted to understand the functional significance of the FcgRIIIa-158F allele in Asian lupus nephritis, as well as to understand how this association may be contributing to some aspects of lupus within and across select ethnic backgrounds. Another small study in this issue[23] did not show association of CTLA4 polymorphisms in 180 Iranian SLE patients compared to 304 controls; however, the study was likely underpowered and lacks assessment of the potential impact of population stratification. selleck compound Two lupus papers in this

journal edition approach novel areas in potential lupus pathogenesis and biomarker development in patients from China. One of them focuses on Organelle membranes that undergo conformational changes to tubuloreticular structures (TRS) after physiological stressors, such as viral infections, starvation and various

disease states. Mak and colleagues[24] demonstrate that supra-physiological levels of interferon-alpha can induce TRS as measured Adenosine by transmission electron microscopy in cell lines in a dose-dependent fashion. In addition, the frequency of TRS mean range in PBMCs of lupus patients was significantly higher compared to that of healthy subjects and the higher TRS scores correlated with increased SLEDAI levels. Additional information is needed regarding whether the patients with higher levels of TRS also had higher interferon signatures or interferon activity. In addition, at least five of the 15 SLE patients tested had no detectable TRS and how those patients differed from the other patients is not clear. Finally, if these associations are confirmed in larger, longitudinal studies, then the mechanisms by which TRS might be driving lupus pathogenesis will need to be discovered; however, this is a novel area of investigation which warrants additional study. Another small and elegant study in the current issue, also from China[25], by Lin Jin et al. reports CD24hiCD27 + CD19 + B cells as a biomarker for new onset SLE, as well as for SLE in longitudinal samples. These results sound promising and replication studies are needed.